Medical Equipment

An Important Factor Driving the Artificial Lung Market Is the The Rising Prevalence Of Respiratory Diseases Fuels Artificial Lung Market

March 10, 2026March 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Artificial Lung Market During The Forecast Period 2026–2030?

The artificial lung market has experienced significant expansion recently. Its size is expected to climb from $2.58 billion in 2025 to $2.88 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.6%. This market’s historical growth can be attributed to factors such as an increase in acute respiratory failure cases, the early adoption of heart-lung machines in cardiothoracic surgery, a rise in organ transplant procedure volumes, the progression of membrane artificial lung technology, and the growing utilization of extracorporeal life support systems.

The artificial lung market is anticipated to experience substantial growth in the coming years. It is projected to reach $4.27 billion in 2030, showing a compound annual growth rate (CAGR) of 10.4%. This projected expansion can be attributed to several factors, including the rising need for critical care life-support devices, a heightened focus on portable and compact artificial lung systems, increased investment in advanced oxygenation membrane materials, the broadening scope of applications in emergency and trauma care, and the greater embrace of minimally invasive extracorporeal support solutions. Significant trends during this forecast period involve an escalating demand for artificial lung systems in severe respiratory failure and critical care management, the increasing adoption of extracorporeal support devices in intricate cardiac and lung transplant surgeries, a developing preference for minimally invasive and temporary lung support alternatives to transplantation, the ongoing development of portable and transport-compatible artificial lung units for emergency care environments, and the expanding utilization of membrane-based artificial lung technologies for efficient gas exchange and long-term support.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16591&type=smp

Which Economic Or Industry Drivers Are Impacting The Artificial Lung Market?

The increasing incidence of respiratory ailments is projected to propel the expansion of the artificial lung market moving forward. The growing prevalence of respiratory diseases results from a combination of factors, including escalating air pollution, climate change, and lifestyle modifications, which collectively place a significant burden on public health. Artificial lungs are utilized in respiratory conditions to ensure oxygenation and remove carbon dioxide from the blood, thereby assisting or replacing compromised lung function. For example, in June 2024, data from the Australian Institute of Health and Welfare, a health and welfare agency based in Australia, indicated that an estimated 8.5 million people in Australia, equating to 34% of the population, were living with chronic respiratory conditions. This total included approximately 2.8 million people, or 11% of the population, diagnosed with asthma, and 638,000 individuals, or 2.5% of the population, affected by chronic obstructive pulmonary disease (COPD). Hence, the rising occurrence of respiratory diseases is stimulating the growth of the artificial lung market.

What Market Segments Are Evaluated Within The Artificial Lung Market?

The artificial lung market covered in this report is segmented –

1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung

2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications

3) By End-Users: Hospital, Emergency Center, Other End-users

Subsegments:

1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines

2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines

3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung

4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung

What Industry Trends Are Redefining The Artificial Lung Market?

Leading firms within the artificial lung market are concentrating on developing innovative solutions, such as genuinely portable pneumatic ECMO systems, to extend extracorporeal life support beyond the ICU and facilitate rapid transport and field deployment. Such pneumatic portable ECMO systems operate using oxygen-supply-driven pneumatic pumps and integrated gas management, providing extracorporeal oxygenation and circulatory support without requiring external electric power or heavy motorized components. For instance, in May 2024, Hemovent GmbH, a Germany-based medical device company, announced that MOBYBOX, recognized as the world’s inaugural integrated portable pneumatic ECMO system, successfully completed its initial commercial applications in Europe. MOBYBOX weighs approximately 2.5 kg, functions solely by its oxygen supply thus operating without a battery or motor, incorporates Bionique Flow Technology for gentler blood handling and improved gas exchange, and has secured Medical Device Regulation certification for its initial markets.

Who Are The Top Market Participants Influencing The Artificial Lung Market?

Major companies operating in the artificial lung market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co KGaA, ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomédica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB‑Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare, Cytosorbents Corporation

Read the full artificial lung market report here:

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

What Are The Top-Performing Regions Within The Artificial Lung Market?

North America was the largest region in the artificial lung market in 2025. The regions covered in the artificial lung market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Artificial Lung Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16591&type=smp

Browse Through More Reports Similar to the Global Artificial Lung Market 2026, By The Business Research Company

In Vitro Lung Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Artificial Intelligence Ai In Respiratory Diseases Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

Respiratory Devices And Equipment Therapeutic Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795